RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov 1, 2023--IQVIA Holdings Inc. (鈥淚QVIA鈥�) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended ...
SAN DIEGO--(BUSINESS WIRE)--Nov 1, 2023--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or 鈥淐alidi鈥�), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced two key promotions from the clinical leadership team and the appointment ...
VAUGHAN, Ontario--(BUSINESS WIRE)--Nov 1, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2023 financial results.鈥淲e continue to grow revenue at or above market ...
RAHWAY, N.J.--(BUSINESS WIRE)--Nov 1, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., is scheduled to participate in a fireside chat at the UBS BioPharma Conference on Wednesday. Nov. 8, 2023, ...
SOMERVILLE, Mass., & BUFFALO, N.Y.--(BUSINESS WIRE)--Nov 1, 2023--Generate:Biomedicines and Roswell Park Comprehensive Cancer Center today announced a strategic collaboration to discover and develop chimeric antigen receptor (CAR) T-cell therapies, and armoring technologies, for up ...
WILMINGTON, Del.--(BUSINESS WIRE)--Nov 1, 2023--Phreesia, Inc. (NYSE: PHR) (鈥淧hreesia鈥�) today announced that it will release its fiscal third quarter 2024 financial results after the close of market trading on Tuesday, December 5, 2023. Phreesia will issue a press release announcing its ...